申请人:Wu Tom Yao-Hsiang
公开号:US20100120859A1
公开(公告)日:2010-05-13
The present invention relates to piperidine-based renin inhibitor compounds having carboxylate or carboxylic acid terminal groups, and their use in treating cardiovascular events and renal insufficiency.
本发明涉及基于哌啶的肾素抑制剂化合物,其具有羧酸盐或羧酸末端基团,并且它们在治疗心血管事件和肾功能不全方面的使用。